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Mushrooms for ages have been used by humans, not only as a source of food but as medicinal re-
sources as well. They were used as a part of traditional medicine, first of all in the civilizations of the
East and recently in Western civilizations. The mushrooms constitute 16,000 species worldwide with
more than 2000 species identified as safe. Among these mushrooms, 1000 are edible, while others have
been used as a source of biofuel, in medicinal formulation, as biochemicals, and for other purposes.
Mushrooms have also huge potential, such as a “mushroom pharmaceuticals” with 130 medicinal
functions. Therefore, they have been considered as potential source of antioxidant, antitumor, an-
tiviral, antimicrobial, and immunomodulatory agents. This review focuses on the antimicrobial and
analgetic activities of some medicinal mushrooms.
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1. INTRODUCTION
Fungi are group of organisms belonging to separate kingdom
according to Whittaker (1969) classification. The fungi are
most diverse groups of organisms on Earth assumed that total
of more than 1,5 million species. Currently, 100,000 species
of fungi of all kinds have been described (Blackwell, 2011).
The mushrooms constitute 16,000 species, calculated from the
Dictionary of Fungi (Kirk et al., 2008) with approximately 700
species, with the pharmacological properties of 2000 known,
safe species (Wasser, 2010).
The term mushroom will be used for a distinctive fruiting
body (epigeous or hypogeous) of higher fungi. Mushrooms
are (mostly higher Basidiomycetes and some Ascomycetes)
macromycetes within fruiting bodies large enough to be seen
with the naked eye and to be picked up by hand (Chang
and Miles, 2004). Usage of medicinal mushrooms has a long
history in different folk’s medicines and in prevention and
treatment of many diseases, especially in countries such as
China, India, Japan and Korea, but also in of eastern European
countries, Mesoamerica, Africa, Algeria, and Egypt (Wasser,
2014).
Medicinal mushrooms (MM) can be defined as macroscopic
fungi, which are used in the form of extracts or powder for
prevention, alleviation or healing multiple diseases, and/or
in balancing a healthy diet. There is a total more than 130
medicinal functions produced by MMs and fungi (Gargano
et al., 2017).
The mushrooms possessed high content of proteins (20–30%
of dry matter), and all the essential amino acids are presented.
They are rich in chitin as a source of dietary fiber and have
high vitamin B content. The mushrooms are low in total fat
but with a high proportion of unsaturated fatty acids, and
have no cholesterols. They have been used not only as a
source of delicious foodstuff and also as a source of food fla-
voring substances but medicinal resource as well. The medic-
inal properties of mushrooms have been confirmed through
an intensive research conducted worldwide (Valverde et al.,
2015). Mushrooms possess immense nutritional and medicinal
bio-components that substantiate their usage in maintaining
global public health. It was shown that they constitute a rich
source of bioactive compounds exhibiting antitumor, hypoc-
holesterolemic, immunosuppressive, antioxidant, antimicro-
bial and anti-inflammatory properties. These compounds
are polysaccharides, complexes (polysaccharide–protein and
polysaccharide–peptide), ribonucleases, proteases, and lectins.
Other mushroom compounds of therapeutic interest are the
secondary metabolites, especially some low molecular weight
compounds such as lactones, terpenoids, and alkaloids, an-
tibiotics with different chemical groups, and metal chelating
agents (Cheung, 2010; Wasser, 2011). Many species of mush-
rooms are used in traditional medicine, but the following
are the most valuable: Ganoderma lucidum, Lentinus edodes,
Trametes versicolor, Schizophyllum commune, Flammulina velu-
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tipes, Pleurotus ostreatus, Agaricus bisporus, A. brasiliensis, Tri-
choloma matsutake, Auricularia auricula, Grifola frondosa, Cordy-
ceps sinensis, Coprinus comatus, Inonotus obliquus, Phellinus lin-
teus, Laetiporus sulphureus, and Hericium erinaceus. These and
other species are referred as "medicinal mushrooms" due to
their long history of medical use. The biologically active com-
pounds and extracts from this species exhibit a broad spectrum
of pharmacological activities (Chang and Wasser, 2012; Fan
et al., 2006; Lindequist et al., 2005; Muszynska et al., 2015; Pa-
terson and Lima, 2014; Roupas et al., 2012; De Silva et al., 2013;
Stachowiak and Regula, 2012; Wasser, 2010; 2014).
In this review, the special attention is paid on antimicrobial
activities of selected mushrooms and their positive analgetics
effect of in the treatment of pain.
2. ANTIMICROBIAL ACTIVITY OF EDIBLE AND
MEDICINAL MUSHROOMS
Antimicrobial agents are substances used to treat infections
caused by pathogenic microorganisms. These compounds
achieve activity through several mechanisms, which specifi-
cally acts on the specific processes in the bacterial cell (DNA
replication and transcription, inhibition of certain enzymes)
or their structures (ribosomes, cell wall and membrane) in
the bacterial and fungal cells in order to enable their growth
(Madigan and Martinko, 2006). The antifungal agents can form
a complex with ergosterol compromising the cell membrane
fluidity or other antifungals inhibit the synthesis of enzyme
that catalyzes a critical reaction of the sterol biosynthetic path-
way, leading to the depletion of ergosterol in the membrane
or other antifungal classes inhibit glucan biosynthesis. The de-
velopment of new antimicrobials, both natural and synthetic,
is critical due to the increasing number of isolated multi-drug
resistant microorganisms on the environment, human and vet-
erinary medicine. Antimicrobial compounds with more or less
strong activities could be isolated from many mushrooms and
that they could be of benefit for human (Sokovic et al., 2017).
There are many literature data concerning in vitro studies of
antimicrobial potential of mushroom extracts, where tested
extracts demonstrated activities against gram-positive and
gram-negative bacteria as well as foodborne pathogenic bac-
terial strains, yeasts and micromycetes: phytopathogens and
dermatomycetes (Soboleva et al., 2006; Hearst et al., 2009; Ja-
gadish et al., 2009; Venturini et al., 2008).
1. Antibacterial activity of extracts and compounds isolated
from mushrooms
According to the World Health Organization (WHO, 2001)
despite the wide variety of existing antibiotics and antimy-
cotics treating of bacterial and fungal infections has become an
increasingly complicated task due to the development of mi-
crobial resistance to existing antimicrobial drugs. For example,
some of the microorganisms that have developed resistance
to antibiotics are penicillin-resistant Streptococcus pneumoniae,
vancomycin-resistant Enterococci, methicillin-resistant Staphy-
lococcus aureus (MRSA), and multi-resistant Salmonellae and
Mycobacterium tuberculosis. Many infections are multidrug re-
sistant, with a mortality rate of nearly 400 deaths per year
(Ventola, 2015).
The antimcrobial potential of mushroom species depends on
samples origin, type of extract, assays applied and bacterial
and fungal species investigated, as well as the numerical val-
ues of the results are presented (Alves et al., 2012a; Barros
et al., 2007; Harikrishnan et al., 2011; 2012). A large number
of species from phylum Basidiomycota are known to be pro-
lific producers of antibacterial bioactive metabolites. Some
mushroom extracts, particularly obtained from Lentinus edo-
des and Phellinus linteus, have been reported as effective even
against highly resistant bacteria, such as MRSA (Hearst et al.,
2009; Hur et al., 2004). L. edodes ethyl acetate extract showed
inhibitory activity against Bacillus cereus, B. subtilis, Staphylo-
coccus aureus and S. epidermidis. Streptococcus pyogenes was very
sensitive to the chloroform extract of Lentinus edodes, while
aqueous extract demonstrated good activity against MRSA.
L. edodes extracts showed a strong bactericidal effect against
Streptococcus mutans (Alves et al., 2012a).
Agaricus genus represents the most important cultivated edi-
ble mushroom. Antimicrobial activity of three Agaricus species
was published by Ozturk et al. (2011), who described effects
of methanolic extracts against six species of Gram-positive
bacteria, seven species of Gram-negative bacteria. Giri et al.
(2012) described that a methanolic extract of A. campestris from
India showed antimicrobial activity against seven bacterial
species. Glamoclija et al. (2015) investigated biological activity
of methanolic and ethanolic extracts of A. bisporus, A. bitorquis,
A. campestris and A. macrosporus. All extracts showed antibac-
terial potential. The biofilm forming capability of P. aerugi-
nosa was also reduced in a concentration-dependent manner.
Furthermore, ethanolic extracts demonstrated statistically sig-
nificant reduction of virulence factors such as AQ inhibition
zones, twitching and swimming motility of the tested bacteria.
Petrovic et al. (2014a) showed good antibacterial activity of
different extracts (aqueous and methanolic) of Laetiporus sul-
phureus fruiting body against tested bacteria, being in some
cases stronger than the used antibiotics.
In a recent screening of antibacterial activity of water and
methanol crude extracts of the species, Meripilus giganteus
against nine species of Gram-positive and four species of
Gram-negative bacteria, the most active extract was methano-
lic, inhibiting all the Gram-positive bacteria and only two
Gram-negative ones (Karaman et al., 2009). Stojkovic et al.
(2017) demonstrated he activity of the methanolic extract of
M. giganteus decreased in the order: S.aureus = B. cereus > S.
typhimurium > E. coli > L. monocytogenes > M. flavus = P. aerugi-
nosa > E. cloacae. Karaman et al. (2010), even though applying
different method, also found S. aureus strain as the most sensi-
tive to the antimicrobial action of M. giganteus.
Antimicrobial activities and the antiquorum effect on Pseu-
domonas aeruginosa of Agrocybe aegerita methanolic extract were
investigated. The A. aegerita methanolic extract regulated the
virulence factors in the quorum sensing (QS) test, as well
as biofilm formation on P. aeruginosa (Petrovic et al., 2014b).
Extracts from the fruit bodies of the medicinal mushroom Heri-
cium erinaceus inhibited the adverse in vivo effects of Salmonella
in mice via stimulation of the immune system (Kim et al.,
2012). The high antibacterial activity was observed for Gan-
oderma lucidum and Coprinus species. Numerous studies on
the potential of G. lucidum are well documented. Heleno et al.
(2013a) present is a good activity of methanol extract of G.
lucidum on S. aureus, B. cereus, M. flavus, L. monocytogenes,
E. coli, S. typhimurium, P. aeruginosa, and E. cloacae. Antimi-
crobial activities of Ganoderma lucidum, G. praelongum and G.
resinaceum were evaluated against 30 strains of clinical isolates
of methicillin-resistant and -sensitive Staphylococcus aureus
(Ameri et al., 2011). Coprinol, a new antibacterial cuparane-
type terpenoid from cultures of a Coprinus sp. exhibited ac-
tivity against multidrug-resistant Gram-positive bacteria Jo-
hansson et al. (2001). Micaceol, a sterol and (Z,Z)-4-oxo-2,5-
heptadienedioic acid were isolated from Coprinus (Coprinopsis)
micaceus with activities against Corynebacterium xerosis and S.
aureus (Zahid et al., 2006).
Ramariolides A–D, isolated from the fruiting bodies of the
coral mushroom Ramaria cystidiophora, showed in vitro an-
timicrobial activity against Mycobacterium smegmatis and M.
tuberculosis (Centko et al., 2012). The Armillaria mellea, which
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produces antibiotic, melleolides, unusual sesquiterpene ester
(Baumgartner et al., 2010; Bohnert et al., 2014), showed high
antibacterial potential. The capacity of methanolic extract of
A. mellea indicates the possible presence of compounds with a
broad spectrum of activity to interfere with quorum-sensing
regulated functions (biofilm formation, pyocyanin production,
bacterial motility), which might have great potential in the
near future (Kostic et al., 2017)).
Some of the tested Ascomycetes, as Morchella esculenta and
Tirmania pinoyi, as well showed excellent antibacterial activ-
ity. The methanolic extracts of M. esculenta exhibited very
good activity against five bacteria (Heleno et al., 2013b). It
was noticed that T. pinoyi methanolic extract dissolved in dif-
ferent solvents, showed antibacterial activities against food
poisoning and food spoilage bacteria demonstrated in vitro
and in situ. Activities of Tirmania pinoyi methanolic extract
successfully inhibited the growth of S. aureus in chicken soup
(Stojkovic et al., 2013a).
2. Antifungal activity of extracts and compounds isolated
from mushrooms
Pathogenic fungi are capable to induce infections of humans,
animals, crops, and other living organisms. The main
pathogens responsible for fungal infections are yeasts, moulds
and dermatomycetes. Fungal infections contribute substan-
tively to human morbidity and mortality. Candida spp., the
yeast-like fungi, is one of the most common infectious agents.
This genus as the 5th most common pathogen associated
with bloodstream infections, while skin mycosis affects
approximately 25% of the world’s population (Havlickova
et al., 2008). In agriculture, fungal invasion brings about
serious reduction in the quality and yield of crops and incurs
enormous economic losses. After fungal attack, the crops may
be contaminated with toxic secondary metabolites produced
by fungi, mycotoxins. This contamination of food and feed
crops may occur in various stages of the food chain. The
species from genera Penicillium, Aspergillus and Fusarium
are among the best known and widely studied moulds
that mostly contaminate agricultural products and produce
mycotoxins (Bryden, 2012; Zain, 2011). Just because of that
in recent years there has been an increased use of antifungal
agents and has resulted in the development of resistance and
toxicity, low efficacy rates. This has given rise to a search for
new natural antifungal agents.
Macrofungi seem greatly promising in terms of compounds
with potential biological activities (Alves et al., 2013).
Mushroom extracts, primary and secondary metabolites from
mushrooms have been associated with their antimicrobial
properties, such as oxalic acids, peptides or proteins, and
terpenes, steroids or benzoic acids derivatives (Alves et al.,
2012b). The compounds of different biogenetic origins have
been isolated from Basidiomycota and were found to have
antifungal activity. A total of 103 isolates of basidiomycetes,
representing 84 species from different Brazilian ecosystems,
were used in a bioassay panel (Rosa et al., 2003).
The diversity and abundance of mushrooms in Serbia is large
(between 10,000 and 20,000 different species) and can be
attributed to favorable climatic and geographic conditions,
as well as plant diversity, however, is the lack of data on
the bioactive properties of mushrooms increased interest
in domestic scientific community about these properties
(Karaman et al., 2014). Until recently, macromycetes in
Serbia are primarily considered a delicacy high nutritional
value and organoleptic properties, while their potential
medical application was in the background. Considering a
large number of new data indicate that macromycetes says
pharmacodynamic agents, there is a perspective to change
these facts. Moreover, our research group has an extensive
work in the antifungal characterization of wild and cultivated
mushroom species from Serbia and other countries. The
antifungal potential of extracts of different macromycetes
(Agaricus bisporus, A. bitorquis, A. campestris, A. macrosporus
(syn. A. albertii), A. bohusii, A. brasiliensis (syn. A. blazei),
Agrocybe aegerita, Armillaria mellea, Boletus aereus, Coprinus
comatus, Coprinopsis atramentaria, Clitocybe subconnexa, Gano-
derma lucidum, Laetiporus sulphureus, Macrolepiota procera, M.
mastoidea, M. rachodes, Meripilus giganteus, Morchella esculenta,
M. conica, Pleurotus ostreatoroseus, Polyporus squamosus, Suillus
granulatus, Inonotus obliquus, Cordyceps militaris, Phellinus
linteus, Tirmania pinoyi, Volvopluteus gloiocephalus) have been
evaluated in vitro and in situ.
The in vitro antimicrobial activity of mushroom extracts
obtained from different extraction solvents has been investi-
gated by the microdilution method on panel of pathogenic
microfungi (Petrovic et al., 2014b; 2013; 2014a;c; Reis et al.,
2014a; 2013; 2014b; 2012; Stojkovic et al., 2013b;a; 2014a;b).
Laetiporus sulphureus proved to be a very successful biocontrol
agent in situ food system (tomato paste and chicken patè),
having dose-dependent and time-dependent influence on
food borne pathogen Aspergillus flavus (Petrovic et al., 2013;
2014c).
Armillaria mellea methanolic extracts exhibited great anti-
candidal potential. Four strains of Candida albicans (clinical
isolates from human) were tested for their susceptibility to
the methanolic extract, and the results indicate very good
antifungal effect of tested extract (Kostic et al., 2017).
Extract of Cordyceps militaris showed very good antifungal
activity against Penicillium ochrochloron, P. funiculosum and
Trichoderma viride (Wang et al., 2012). This study proved that
extracts of C. militaris could be used as a good alternative to
synthetic antimicrobial agents in prevention and treatment
of different plant, animal, human pathogenic species, and
food-borne pathogens. Another bioactive compound from
C. militaris is cordymin. This peptide was studied for its
antifungal properties and found to inhibit mycelial growth of
Bipolaris maydis, Mycosphaerella arachidicola, Rhizoctonia solani
and Candida albicans (Reis et al., 2013).
Eryngin, an antifungal peptide isolated from Pleurotus eryngii
fruiting bodies, also gave activity against F. oxysporum and
M. arachidicola. Another peptide, pleurostrin, isolated from
Pleurotus ostreatus showed antifungal activity against F.
oxysporum, M. arachidicola and P. piricola (Chu et al., 2005).
Agrocybin, an antifungal peptide isolated from Agrocybe
cylindracea showed activity against M. arachidicola (Ngai et al.,
2005).
In fact, there is a gap in the identification of the individual
compounds responsible for antifungal properties. Among
identified single compounds from mushrooms extracts, a
few low-molecular-weight compounds, some peptides, and
proteins have been described. In the study Alves et al. (2013)
and Sokovic et al. (2017) different extracts and some low
molecular weight (LMW) and high molecular weight (HMW)
compounds isolated from mushroom with antifungal activity
are reported. The sesquiterpenes, enokipodim F, G and I,
isolated from Flammulina velutipes mycelium presented low
activity against Aspergillus fumigatus (Wang et al., 2012).
Phenolic acids and related compounds such as p-
hydroxybenzoic and cinnamic acids identified in Ganoderma
lucidum also revealed activity against different fungi species,
such as Aspergillus fumigatus, A. versicolor, A. ochraceus, A.
niger, Trichoderma viride, Penicillium funiculosum, P. ochrochloron
and P. verrucosum. The mentioned compounds gave higher
activity than antimycotics (Heleno et al., 2013a).
Some studies suggested that mushrooms could be used also
Review Article Lekovite Sirovine vol. 37 (2017) 53
as inhibitors of mycotoxins production. Culture filtrates
from Lentinula edodes and Trametes versicolor have revealed
promising aflatoxin-inhibiting effects (Reverberi et al., 2005;
Zjalic et al., 2006).
3. ANALGETICS EFFECT OF MEDICINAL MUSH-
ROOMS
There has been an increasing interest in the health-enhancing
role of functional foods or physiologically-active food
compounds. One of the most important traits of some
functional food ingredients, in addition to their nutritional
values, is their physiological benefit. Many recent studies
have reported that components from mushrooms play a
very important role in health promotion (Morris et al., 2017).
The term “functional foods” has been described as foods
that “should have a relevant effect on well-being and health
or result in a reduction in disease risk” (Roberfroid, 1999).
Mushrooms are attractive as a source of functional food
and medicines to treat cancer and as therapeutic approach
for inflammation-associated disorders such as rheumatoid
arthritis, psoriasis, and other autoimmune afflictions. Pain is
an unpleasant sensation usually associated with these and
other diseases.
Many edible mushrooms such as species from genus Pleurotus,
Agaricus and Lactarius exhibited analgetic effect (Wang et
al., 2013). Pleurotus spp., mainly P. ostreatus, P. pulmonarius,
P. eryngii and P. djamor are known as “oyster” mushrooms.
There have been some reports showing that P. pulmonarius
have analgetic effects (Baggio et al., 2012; 2010; Smiderle et al.,
2008). Smiderle et al. (2008) isolated β-glucan from P. pul-
monarius and found the glucan had potent anti-inflammatory
and antinociceptive activities in mice. Animals treated
with β-glucan showed a reduction of neurogenic pain and
inflammatory pain.
Fucogalactans from Agaricus brasiliensis (EPF-Ab) and A.
bisporus var. hortensis (EPF-Ah) have a positive role in
antinociceptive, anti-inflammatory, and anti-sepsis (Komura
et al., 2010). Agaricus macrosporus is another species which
has obvious analgetic effect by inhibiting neurolysin with
agaricoglycerides, a new class of fungal secondary metabolites
that constitute esters of chlorinated 4-hydroxy benzoic acid
and glycerol produced in cultures (Stadler et al., 2005).
Ruthes et al. (2013) studied and found that Lactarius rufus had
the anti-inflammatory and antinocicep¬tive potential of their
polysaccharides evaluated using the formalin model. Soluble
β-d-glucan isolated from fruiting bodies of L. rufus produced
potent inhibition of inflammatory pain caused by formalin.
Not only genera described above, but also many others have
the effect of analgesia. Van Griensven et al. (2017) concluded
that the different Inonotus obliquus extracts consist mostly
of lignin derivatives. Their application (intra-peritoneal
in mice) suppressed the nociception of the inflammatory
phase induced by formalin. The phenolic acid isolated from
Schizophyllum commine has been found as an analgetic in rat’s
neurons. Smiderle et al. (2013) demonstrated suppression
of formalin-induced nociceptive response of mice by glucan
purified from cultivated Cordyceps millitaris fruiting bodies.
The active components with analgetic effects are identified
from many mushrooms (Van Griensven et al., 2017). However,
further research is required prior to clinical trials and applica-
tions to humans. The main interest of research is now to find a
drug that provides excellent analgetics effect, with little or no
harmful effect on the organism. Also, many research efforts
are focused on finding new compounds or formulations which
could reduce or prevent the negative effects of drugs which
are used in the treatment of pain. Particularly it is desired the
discovery of novel prototype therapeutic agents representing
new chemical classes, operating by different modes of action
compared to the existing agents and, consequently, lack
cross-resistance to chemicals currently used.
CONCLUSION
Most evidence regarding the beneficial antimicrobial effects
of a large number of mushroom varieties and mushroom ex-
tracts and components on bacteria, yeast, and pathogenic
micromycetes have been confirmed via in vitro studies. Nu-
merous of animal studies have been undertaken and the data
suggest that the antimicrobial effects in vivo may be mediated
by effects on the immune system (De Silva et al., 2013) Clinical
studies investigating the influence of mushroom preparations
on pathological disorders are very rare. Mushroom extracts
and fungal compounds are being investigated in clinical trials
by National Institutes of Health in the US; Hospital Clinic of
Barcelona and others hospital (Morris et al., 2017). In the fu-
ture, we expect more numerous clinical trials that will acceler-
ate the commercial production „mushroom pharmaceuticals”.
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